EA201990817A1 - ANTI-CD27 ANTIBODIES - Google Patents

ANTI-CD27 ANTIBODIES

Info

Publication number
EA201990817A1
EA201990817A1 EA201990817A EA201990817A EA201990817A1 EA 201990817 A1 EA201990817 A1 EA 201990817A1 EA 201990817 A EA201990817 A EA 201990817A EA 201990817 A EA201990817 A EA 201990817A EA 201990817 A1 EA201990817 A1 EA 201990817A1
Authority
EA
Eurasian Patent Office
Prior art keywords
antibodies
cancer
diseases
treatment
well
Prior art date
Application number
EA201990817A
Other languages
Russian (ru)
Inventor
Эми М. Биб
Джейсон Ка Джен Чеунг
Вероника Цзюань
Лоренс Фаядат-Дилман
Светлана Садекова
Джерелин Вонг
Тьерри Оливер Фишманн
Винифред В. Просизе
Ханс Ван Эненнам
Андреа Ван Элсас
Ларс Гюлен
Original Assignee
Мерк Шарп И Доум Корп.
Мерк Шарп и Доум Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Шарп И Доум Корп., Мерк Шарп и Доум Б.В. filed Critical Мерк Шарп И Доум Корп.
Priority claimed from PCT/US2017/053204 external-priority patent/WO2018058022A1/en
Publication of EA201990817A1 publication Critical patent/EA201990817A1/en

Links

Abstract

Настоящее изобретение относится к анти-CD27 антителам, а также к применению таких антител для лечения заболеваний, таких как рак и инфекционное заболевание.The present invention relates to anti-CD27 antibodies, as well as to the use of such antibodies for the treatment of diseases such as cancer and an infectious disease.

EA201990817A 2017-08-16 2017-09-25 ANTI-CD27 ANTIBODIES EA201990817A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762546214P 2017-08-16 2017-08-16
PCT/US2017/053204 WO2018058022A1 (en) 2016-09-26 2017-09-25 Anti-cd27 antibodies

Publications (1)

Publication Number Publication Date
EA201990817A1 true EA201990817A1 (en) 2019-08-30

Family

ID=67734926

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201990817A EA201990817A1 (en) 2017-08-16 2017-09-25 ANTI-CD27 ANTIBODIES

Country Status (1)

Country Link
EA (1) EA201990817A1 (en)

Similar Documents

Publication Publication Date Title
EA201790413A1 (en) ANTIBODIES AGAINST TIGIT
MX2019012233A (en) Anti-sirp alpha antibodies.
MX2022007522A (en) Anti-cd27 antibodies.
EA201990912A1 (en) ANTI-LAG-3 ANTIBODIES AND THEIR COMPOSITIONS
EA201890145A1 (en) ANTIBODIES TO FACTOR XI AND METHODS OF THEIR APPLICATION
EA202091898A1 (en) ANTIBODIES THAT NEUTRALIZE THE HUMAN IMMUNODEFICIENCY VIRUS
EA201890530A1 (en) CONJUGATES ANTIBODIES TO DLL3 AND MEDICINES AND METHODS OF THEIR USE
EA201890131A1 (en) IMMUNOMODULATION AND TREATMENT OF SOLID TUMORS BY ANTIBODIES THAT SPECIFICALLY CONNECT CD38
EA201790932A1 (en) DOSAGE AND ADMINISTRATION OF NONFUCULATED ANTI-CD40 ANTIBODIES
EA201591514A1 (en) ANTIBODIES TO PAN-HEMOKINES OF THE ELRCXC SUB-FAMILY
CO2017001087A2 (en) Anti angiopoietin-like protein 4 antibodies
EA201890347A1 (en) ANTIBODIES AND RESEARCH FOR DETECTION CD37
EA201990817A1 (en) ANTI-CD27 ANTIBODIES
EA201991851A1 (en) ANTIBODIES AGAINST SIRP-ALPHA
EA202091619A3 (en) ANTIBODIES AGAINST TIGIT
EA202192418A1 (en) METHODS OF TREATMENT OF AL-AMYLOIDOSIS
EA202092947A1 (en) ANTI-PVRIG / ANTI-TIGIT BISPECIFIC ANTIBODIES AND METHODS OF THEIR APPLICATION
EA201791389A1 (en) METHODS AND COMPOSITIONS OF ANTIBODIES ARE DIRECTED AGAINST BMP6
ECSP17016755A (en) ANTI TIGIT ANTIBODIES